Biomet: SEC: Biomet Charged With Repeating FCPA Violations
Washington D.C.--(Newsfile Corp. - January 12, 2017) - The Securities and Exchange Commission today announced that a Warsaw, Ind.-based medical device manufacturer has agreed to pay more than $30 m...
Read full article »
Biomet designs, manufactures, markets and distributes surgical and non-surgical medical devices.
Read more